August 1, 2007

Gentamicin-induced ototoxicity in hemodialysis patients is ameliorated by N-acetylcysteine.

.   .   

Related Articles:

General Nephrology
  • Visitor

    I thought that is was a very interesting study. Given that the majority of catheter-related bacteremia patients are given AG’s empirically, I think that it would be worthwhile considering this “benign” therapy. However, I wonder which subgroup would most benefit. Does anybody have any thoughts?